Bob Silverman
Consultant / Advisor chez The New York City Investment Fund Manager, Inc.
Profil
Bob A.
Silverman currently works at The New York City Investment Fund Manager, Inc., as Advisor and C2i Genomics, Inc., as Chief Business Officer from 2023.
Mr. Silverman also formerly worked at Biohealth Innovation, Inc., as Director, Roche Holding AG, as Venture Capital Lead from 2012 to 2020, Pennie & Edmonds LLP, as Associate, Alloy Therapeutics LLC, as Executive Partner & Chief Business Officer from 2019 to 2021, and Rejuveron Life Sciences AG, as Chief Business Officer from 2021 to 2022.
Mr. Silverman received his undergraduate degree from Franklin & Marshall College and graduate degree from Boston University School of Law.
Postes actifs de Bob Silverman
| Sociétés | Poste | Début |
|---|---|---|
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Consultant / Advisor | - |
C2i Genomics, Inc.
 C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Bob Silverman
| Sociétés | Poste | Fin |
|---|---|---|
| Rejuveron Life Sciences AG | Corporate Officer/Principal | 01/12/2022 |
Alloy Therapeutics LLC
 Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Corporate Officer/Principal | 01/07/2021 |
| ROCHE HOLDING AG | Conseiller Juridique Général | 31/12/2003 |
Pennie & Edmonds LLP
 Pennie & Edmonds LLP Miscellaneous Commercial ServicesCommercial Services Pennie & Edmonds LLP provides legal services. The company was founded on January 27, 1997 and is headquartered in New York, NY. | Corporate Officer/Principal | 31/12/1993 |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | - |
Formation de Bob Silverman
| Franklin & Marshall College | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 6 |
|---|---|
Pennie & Edmonds LLP
Pennie & Edmonds LLP Miscellaneous Commercial ServicesCommercial Services Pennie & Edmonds LLP provides legal services. The company was founded on January 27, 1997 and is headquartered in New York, NY. | Commercial Services |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Finance |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Finance |
Alloy Therapeutics LLC
Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Commercial Services |
C2i Genomics, Inc.
C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Technology Services |
| Rejuveron Life Sciences AG | Finance |
